Improving diabetes management in rural areas using AI and telehealth
Gamified Optimized Diabetes-management with AI powered Rural Telehealth (GODART)
This study is testing a new online program called GODART that uses smart technology to help people with diabetes in rural areas manage their health better by offering fun coaching and support for things like diet, exercise, and medication.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10683381 on NIH RePORTER |
What this research studies
This research focuses on enhancing diabetes management for individuals in rural communities through a telehealth platform called GODART, which utilizes artificial intelligence. The program aims to provide automated behavior monitoring and coaching to help patients adhere to diabetes management guidelines, including diet, exercise, and medication. By employing a gamified approach, the intervention seeks to engage patients more effectively and improve their health outcomes. The project will pilot various components of the system to assess feasibility and effectiveness in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in rural areas who have been diagnosed with type 2 diabetes mellitus.
Not a fit: Patients who do not have access to telehealth services or those with type 1 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better health outcomes for patients in rural areas.
How similar studies have performed: Previous research has shown promise in using telehealth and AI for chronic disease management, indicating potential success for this approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Thirumalai, Mohanraj — University of Alabama at Birmingham
- Study coordinator: Thirumalai, Mohanraj
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.